Image of the Month: A closer look at metastatic medulloblastoma
The image captures metastatic medulloblastoma tumor cells (green) intertwined with blood vessels (magenta) in the leptomeninges of a mouse model of the human condition.
Read More
Partners in crime: Metastatic medulloblastoma recruits local fibroblasts to support its spread and growth
This novel discovery shows how tumor and non-tumor cells work together to create an environment that backs up cancer growth.
Read More
State of the Lester and Sue Smith Breast Center and breast cancer research
Interim director Dr. Xiang “Shawn” Zhang sat down with From the Labs to provide an update on this multidisciplinary center dedicated to breast cancer research and patient care.
Read More
Carbon ultrafine particles accelerate lung cancer progression
Researchers at Baylor College of Medicine discover how airborne ultrafine particles in smoke can change a host’s defense against lung cancer.
Read More
A potentially more effective treatment for HER2 mutant metastatic breast cancer
A phase II clinical trial is on its way to assess the value of poziotinib in the treatment of this devastating condition.
Read More
The bone microenvironment ‘empowers’ cancer cells to become metastatic
The bone microenvironment prompts changes in breast cancer cells that help them escape treatment and become more invasive.
Read More
The single cell and the cluster, what makes one better than the other at cancer metastasis?
Cancer metastasis is all about rogue cancer cells abandoning the original tumor and venturing through the blood in search for new breeding grounds. Sometimes, single
Read More
CD44 variants prompt different cancer cell behaviors
Imagine fighting enemies that differ in their susceptibility to the weapon you are using against them. Some will perish, but others will survive the attack
Read More
An integrated approach to finding new treatments for breast cancer
Unraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And
Read More
Estrogen receptor can affect resistance to endocrine therapy and metastasis in breast cancer
Resistance to therapy is common in estrogen receptor positive (ER+) breast cancer, the most common type of breast cancer, and eventual development of metastatic disease
Read More